Inauspicious Start To Gurry’s Second Term As IP Policymaking Hits Wall At WIPO

General Assembly Chair, Amb. Päivi Kairamo

To hear some delegates’ late night closing statements at the General Assembly last night, developing country goals at the World Intellectual Property Organization died this week, as key issues met roadblocks in every direction. But all member states claimed to be shaken by the crash of WIPO’s normative agenda this week, putting the model for negotiating at the UN agency into question.

Lisbon Agreement Members To Move Ahead With Treaty Talks Despite Resistance

WIPO - Catherine Saez (7)

The revision of a World Intellectual Property Organization agreement to include geographical indications, raising their status, was challenged in vain by some countries in the past week. In addition, this week’s WIPO General Assembly has been working intensively on a range of other issues.

NGOs: Farmers’ Rights Should Be Safeguarded In Activities Of Plant Treaty, WIPO, UPOV

Agriculture - Catherine Saez (1)

Over 50 organisations have co-signed a letter to the International Plant Treaty calling for it to safeguard the implementation of farmers’ rights in the context of joint activities with the World Intellectual Property Organization and the Union for the Protection of New Varieties of Plants (UPOV).

Lisbon GI Revision A Hot Topic As Members Prepare For Treaty Talks

EU GI logo

A proposed amendment to the Lisbon Agreement protecting appellations of origin at the World Intellectual Property Organization is the object of heated discussions between proponents of geographical indications and countries favouring other systems such as trademarks to protect such intellectual property titles. A side event to this week’s WIPO General Assemblies gathered GI proponents to ponder the future of the agreement.

Panellists Discuss Value Of Patent Pooling For HIV/AIDS, Potential For Other Diseases

MPP's Greg Perry speaks, flanked by Duneston (left), Mirza (right), and other panellists

A side event to this week’s World Intellectual Property Organization annual General Assembly highlighted the work of the Geneva-based Medicines Patent Pool in fighting HIV/AIDS, and discussed whether it makes sense for the patent pool model to be extended to other diseases.

Experts Look At The Meaning Of Myriad Case, One Year Later

Cal Irvine law school myriad conf Sept 2014

IRVINE, CALIFORNIA – Experts gathered here last week addressed the question of – one year later – what does the United States Supreme Court’s decision on human gene patents mean for scientific research and patent policy?

Biosimilar Medicines Need Strong Regulation, IP Crucial For Innovation, Pharma Says

Biosimilar medicines might prove to be a new reservoir for innovation for the pharmaceutical industry. However, the complexity of their manufacture needs a stringent regulatory framework, according to the industry.

New Proposal To Keep Indigenous Peoples On WIPO Traditional Knowledge Committee

WIPO IGC

A group of countries has submitted a new proposal to the upcoming meeting of the World Intellectual Property Organization budget committee to allow the continued participation of indigenous peoples representatives in WIPO’s committee on traditional knowledge and genetic resources.

World Drug Regulatory Authorities Meet In Brazil; Biosimilars In Focus

Drug regulatory authorities are meeting this week in Rio de Janeiro, Brazil to discuss global regulatory issues such as vaccine regulation, falsified products, and pharmacovigilance. A “pre-conference” focused on biosimilars, with civil society warning on barriers to access to those products.